James E. Brown - 08 Sep 2025 Form 4 Insider Report for DURECT CORP (DRRX)

Reporting relationship: President & CEO, Director
Issuer ticker: DRRX
Reported as of: 08 Sep 2025
Net transaction value: +$13,000
SEC form: 4
Accepted by SEC: 10 Sep 2025, 21:23:51 UTC
Prior SEC filing: 15 Jul 2025
Next SEC filing: 11 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ James E. Brown

Key filing fact

James E. Brown filed Form 4 for DURECT CORP (DRRX) on 10 Sep 2025.

Key facts

This page summarizes James E. Brown's Form 4 filing for DURECT CORP (DRRX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 Sep 2025, 21:23.

Change

Previous filing in this sequence was filed on 15 Jul 2025.
Current net transaction value: +$13,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001134620 Primary reporting owner

BROWN JAMES E

Relationship: President & CEO, Director
Address: C/O DURECT CORPORATION, 10240 BUBB ROAD, CUPERTINO
Signature: /s/ James E. Brown
Signature date: 09 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DRRX transaction

Common Stock

Options Exercise

Transaction value: $13,000
Shares: +10,000
Change %: +3.7%
Price: $1.30
Shares after: 283,412
Date: 08 Sep 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DRRX transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -10,000
Change %: -2.7%
Price: $0.000000
Shares after: 365,000
Date: 08 Sep 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $1.30
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option will vest and become exercisable in installments of one-sixteenth (1/16) of the total number of shares at the end of each three-month period following the grant date, subject to the Reporting Person providing continuous service to the Issuer through the applicable vesting date.